Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000533426 | SCV000643546 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-12-20 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001683571 | SCV001896707 | likely benign | not provided | 2019-08-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002377096 | SCV002625136 | likely benign | Cardiovascular phenotype | 2019-07-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Revvity Omics, |
RCV001683571 | SCV003825517 | likely benign | not provided | 2023-12-18 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001683571 | SCV004011259 | likely benign | not provided | 2024-09-01 | criteria provided, single submitter | clinical testing | TTN: BP4, BP7 |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003317268 | SCV004020359 | likely benign | not specified | 2023-06-25 | criteria provided, single submitter | clinical testing |